Compass Therapeutics (CMPX) Other Working Capital Changes (2019 - 2026)
Compass Therapeutics recorded quarterly Other Working Capital Changes of $87000.0 in Q1 2026, up 101.82% quarter-over-quarter from -$4.8 million in Q4 2025, and up 134.39% year-over-year from $37118.0 in Q1 2025.
Compass Therapeutics' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at $87000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 134.39% year-over-year to $87000.0; the TTM figure through Mar 2026 stood at -$4.8 million (down 98.5% YoY), while the FY2025 annual figure was -$5.1 million, down 320.38% from the prior year.
- Other Working Capital Changes came in at $87000.0 for Q1 2026 at Compass Therapeutics, up from -$4.8 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $5.0 million in Q2 2024 to a low of -$6.5 million in Q3 2024.
- A 5-year average of -$502941.2 and a median of -$97000.0 in 2022 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 985.31% in 2023 and fell as far as 4755.67% in 2023.
- Compass Therapeutics' Other Working Capital Changes stood at -$463000.0 in 2022, then surged by 985.31% to $4.1 million in 2023, then plunged by 114.08% to -$577000.0 in 2024, then sank by 729.29% to -$4.8 million in 2025, then jumped by 101.82% to $87000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $87000.0, -$4.8 million, and -$37000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87,000.00 |
| Mar 31, 2026 | 87,000.00 |
| Dec 31, 2025 | -4.79 Mn |
| Dec 31, 2025 | -4.79 Mn |
| Sep 30, 2025 | -37,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Jun 30, 2025 | -41,000.00 |
| Jun 30, 2025 | -41,000.00 |
| Mar 31, 2025 | -253,000.00 |
| Mar 31, 2025 | -253,000.00 |
| Dec 31, 2024 | -577,000.00 |
| Dec 31, 2024 | -577,000.00 |
| Sep 30, 2024 | -6.54 Mn |
| Sep 30, 2024 | -6.54 Mn |
| Jun 30, 2024 | 4.96 Mn |
| Jun 30, 2024 | 4.96 Mn |
| Mar 31, 2024 | 936,000.00 |
| Mar 31, 2024 | 936,000.00 |
| Dec 31, 2023 | 4.10 Mn |
| Dec 31, 2023 | 4.10 Mn |
| Sep 30, 2023 | -4.71 Mn |
| Sep 30, 2023 | -4.71 Mn |
| Jun 30, 2023 | -841,000.00 |
| Jun 30, 2023 | -841,000.00 |
| Mar 31, 2023 | 250,000.00 |
| Mar 31, 2023 | 250,000.00 |
| Dec 31, 2022 | -463,000.00 |
| Dec 31, 2022 | -463,000.00 |
| Sep 30, 2022 | -97,000.00 |
| Sep 30, 2022 | -97,000.00 |
| Jun 30, 2022 | -1.86 Mn |
| Jun 30, 2022 | -1.86 Mn |
| Mar 31, 2022 | 1.31 Mn |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | -471,000.00 |
| Dec 31, 2021 | -471,000.00 |
| Sep 30, 2021 | -263,000.00 |
| Sep 30, 2021 | -263,000.00 |
| Jun 20, 2021 | 446,000.00 |
| Jun 20, 2021 | 446,000.00 |
| Mar 31, 2021 | -246,000.00 |
| Mar 31, 2021 | -246,000.00 |
| Sep 30, 2020 | 1.38 Mn |
| Sep 30, 2020 | 1.38 Mn |
| Mar 31, 2020 | 24,000.00 |
| Mar 31, 2020 | 24,000.00 |
| Sep 30, 2019 | -228,000.00 |
| Sep 30, 2019 | -228,000.00 |
| Jun 30, 2019 | 328,000.00 |
| Jun 30, 2019 | 328,000.00 |